3ARROYO S, DODSON WE, PRIVITERA MD, et (d. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy[J]. Acta Neurol Seand, 2005, 112(4): 214-222.
4WHELESS JW, NETO W, WANG S, et ol. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy [J]. J Child Neurol, 2004, 19(2): 135-141.
5GMSELJ J, GUERRINI R, VAN OENE J, et al. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy[J]. Acta Neurol Stand, 2005, 112 (3) : 144-150.
6LEVISOHN PM, HOLLAND KD. Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized openlabel comparison[J]. Epilepsy Behav, 2007, 10(4) : 547-552.
7FRENCH JA, KANNER AM, BAUTISTA J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society[J]. Neurology, 2004, 62(8) : 1252-1260.
8CROSS JH. Topiramate monotherapy for childhood absence seizures: an open label pilot study[J]. Seizure, 2002, 11 (6): 406- 410.
9FRENCH JA, KANNER AM, BAUTISTA J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society[J]. Neurology, 2004, 62(8): 1261-1273.
10PRIVITERA MD, BRODIE M J, MATTSON RH, et al. Topiramate, carhamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy[J]. Acta Neurol Stand, 2003, 107(3): 165-175.
